X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (172) 172
oncology (125) 125
aged (104) 104
index medicus (102) 102
female (100) 100
male (98) 98
middle aged (80) 80
cancer (63) 63
adult (60) 60
chemotherapy (57) 57
aged, 80 and over (42) 42
hematology (39) 39
care and treatment (36) 36
antineoplastic combined chemotherapy protocols - therapeutic use (33) 33
prognosis (31) 31
retrospective studies (31) 31
survival (30) 30
treatment outcome (29) 29
colorectal cancer (27) 27
bevacizumab (26) 26
metastasis (26) 26
therapy (26) 26
antineoplastic agents - therapeutic use (24) 24
research (24) 24
disease-free survival (23) 23
patients (23) 23
clinical trials (22) 22
temozolomide (21) 21
trial (19) 19
survival analysis (18) 18
tumors (18) 18
analysis (17) 17
brain neoplasms - drug therapy (17) 17
glioblastoma (17) 17
italy (17) 17
prospective studies (17) 17
radiotherapy (17) 17
medicine & public health (16) 16
colorectal neoplasms - drug therapy (15) 15
immunohistochemistry (15) 15
pharmacology & pharmacy (15) 15
toxicity (15) 15
cancer patients (14) 14
cancer therapies (14) 14
elderly (14) 14
health aspects (14) 14
metastases (14) 14
neoplasm staging (14) 14
pathology (14) 14
antineoplastic agents - administration & dosage (13) 13
colorectal neoplasms - pathology (13) 13
medical prognosis (13) 13
neoplasm metastasis (13) 13
patient outcomes (13) 13
antineoplastic agents - adverse effects (12) 12
antineoplastic combined chemotherapy protocols - adverse effects (12) 12
expression (12) 12
hematology, oncology and palliative medicine (12) 12
survival rate (12) 12
biomarkers (11) 11
colorectal carcinoma (11) 11
follow-up studies (11) 11
glioblastoma - drug therapy (11) 11
open-label (11) 11
phase-ii (11) 11
risk factors (11) 11
1st-line treatment (10) 10
adjuvant temozolomide (10) 10
adolescent (10) 10
antineoplastic agents (10) 10
carcinoma (10) 10
glioblastoma multiforme (10) 10
non-hodgkins-lymphoma (10) 10
antimitotic agents (9) 9
breast cancer (9) 9
cell biology (9) 9
cell lung-cancer (9) 9
clinical neurology (9) 9
dacarbazine - analogs & derivatives (9) 9
dacarbazine - therapeutic use (9) 9
diagnosis (9) 9
drug therapy (9) 9
irinotecan (9) 9
medicine (9) 9
oncology, experimental (9) 9
prostate cancer (9) 9
quality of life (9) 9
surgery (9) 9
aged patients (8) 8
biopsy (8) 8
biotechnology & applied microbiology (8) 8
bone marrow - pathology (8) 8
cisplatin (8) 8
colorectal neoplasms - genetics (8) 8
disease progression (8) 8
dosage and administration (8) 8
kaplan-meier estimate (8) 8
management (8) 8
medicine, research & experimental (8) 8
mortality (8) 8
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 6, pp. 738 - 746
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 10/2014, Volume 371, Issue 17, pp. 1609 - 1618
In patients with metastatic colon cancer, fluorouracil, oxaliplatin, and irinotecan plus bevacizumab, as compared with fluorouracil and irinotecan plus... 
1ST-LINE TREATMENT | MEDICINE, GENERAL & INTERNAL | INFUSIONAL FLUOROURACIL | LEUCOVORIN | MANAGEMENT | PHASE-III | GUIDELINES | IRINOTECAN | OXALIPLATIN | CHEMOTHERAPY | FOLFIRI | Follow-Up Studies | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Bevacizumab | Fluorouracil - therapeutic use | Antibodies, Monoclonal, Humanized - administration & dosage | Leucovorin - adverse effects | Fluorouracil - adverse effects | Neoplasm Metastasis - drug therapy | Colorectal Neoplasms - drug therapy | Adult | Female | Leucovorin - therapeutic use | Liver Neoplasms - secondary | Camptothecin - analogs & derivatives | Colorectal Neoplasms - mortality | Antibodies, Monoclonal, Humanized - adverse effects | Camptothecin - adverse effects | Camptothecin - therapeutic use | Kaplan-Meier Estimate | Liver Neoplasms - drug therapy | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Aged | Colorectal Neoplasms - pathology | Organoplatinum Compounds - therapeutic use | Organoplatinum Compounds - adverse effects | Treatment outcome | Care and treatment | Analysis | Colorectal cancer | Dosage and administration | Leucovorin | Fluorouracil | Colorectal carcinoma | Diarrhea | Metastasis | Survival | Patients | Clinical outcomes | Metastases | Irinotecan | Stomatitis | Chemotherapy | Neurotoxicity | Oxaliplatin | Monoclonal antibodies | Vascular endothelial growth factor | Neutropenia | Index Medicus | Abridged Index Medicus
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 07/2018, Volume 379, Issue 1, pp. 54 - 63
Journal Article
The Lancet Oncology, ISSN 1470-2045, 07/2018, Volume 19, Issue 7, pp. 940 - 952
Immune checkpoint blockade therapy has shown promising results in patients with advanced hepatocellular carcinoma. We aimed to assess the efficacy and safety... 
CRITERIA | ONCOLOGY | IMMUNOTHERAPY | LANDSCAPE | BLOCKADE | TUMORS | PD-1 | Antimitotic agents | Care and treatment | Product development | Hepatoma | Antineoplastic agents
Journal Article
Human Pathology, ISSN 0046-8177, 2013, Volume 44, Issue 9, pp. 1804 - 1810
Journal Article
Modern Pathology, ISSN 0893-3952, 11/2015, Volume 28, Issue 11, pp. 1481 - 1491
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 01/2002, Volume 20, Issue 2, pp. 494 - 502
To appraise the performance of Comprehensive Geriatric Assessment (CGA) in elderly cancer patients (> or = 65 years) and to evaluate whether it could add... 
Geriatric Assessment | Cross-Sectional Studies | Comorbidity | Health Status Indicators | Humans | Male | Data Collection | Mental Health | Activities of Daily Living | Neoplasms - complications | Sensitivity and Specificity | Aged, 80 and over | Aging | Female | Aged
Journal Article
Human Pathology, ISSN 0046-8177, 2015, Volume 46, Issue 5, pp. 665 - 672
Journal Article